Teradyne price target raised to $117 from $110 at KeyBanc

KeyBanc analyst Steve Barger raised the firm’s price target on Teradyne to $117 from $110 and keeps an Overweight rating on the shares. KeyBanc thinks fundamental conditions for most of its Industrial companies are positive, but the range of share price increases relative to last year’s low is wide, and favors those with solid upside to cyclical recovery and thematic trends like Teradyne, the analyst tells investors in a research note.